Finemedix Co., Ltd. (KOSDAQ:387570)
South Korea · Delayed Price · Currency is KRW 6,100.00
+80.00 (1.33%)
At close: Oct 21, 2026
Finemedix Revenue
Finemedix had revenue of 4.03B KRW in the quarter ending June 30, 2026, with 63.87% growth. This brings the company's total for the last twelve months to 11.43B, up 7.84% year-over-year. In the year 2025, Finemedix had annual revenue of 9.52B, down -4.39%. That makes Finemedix the 38,009th largest company in the world by revenue and 2,412th in South Korea.
Revenue (ttm)
11.43B
Revenue Growth
+7.84%
P/S Ratio
2.90
Revenue / Employee
163.24M
Employees
70
Market Cap
33.13B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.52B | -437.66M | -4.39% |
| Dec 31, 2024 | 9.96B | -193.73M | -1.91% |
| Dec 31, 2023 | 10.15B | 2.01B | 24.71% |
| Dec 31, 2022 | 8.14B | 888.41M | 12.25% |
| Dec 31, 2021 | 7.25B | -656.61M | -8.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Synergy Innovation | 116.56B |
| DENTIS CO.,Ltd | 111.69B |
| Corentec | 104.75B |
| M.I.TECH Co.,Ltd | 70.72B |
| BIOBIJOU | 28.56B |
| Alpha AI | 14.56B |
| Sanigen Co. | 14.21B |
| Genolution | 10.03B |